20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ALOGLIPTIN BENZOATE, with a corresponding US DMF Number 30093.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 08, 2016, and payment made on December 18, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II